Oliver T - Search Results

1

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

Tookman L, Rashid S, Matakidou A, Phillips M, Wilson P, Ansell W, Jamal-Hanjani M, Chowdhury S, Harland S, Sarwar N, Oliver T, Powles T, Shamash J. Tookman L, et al. Among authors: oliver t. Acta Oncol. 2013 Jun;52(5):987-93. doi: 10.3109/0284186X.2012.714078. Epub 2012 Sep 3. Acta Oncol. 2013. PMID: 22943385

2

Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients.

Alifrangis C, Sharma A, Chowdhury S, Duncan S, Milic M, Gogbashian A, Agarwal S, Sahdev A, Wilson P, Harland S, Stoneham S, Lockley M, Rustin G, Oliver T, Berney D, Shamash J. Alifrangis C, et al. Among authors: oliver t. Eur J Cancer. 2022 Mar;164:105-113. doi: 10.1016/j.ejca.2020.08.031. Epub 2020 Oct 8. Eur J Cancer. 2022. PMID: 33041185

3

The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis.

Powles T, Robinson D, Shamash J, Moller H, Tranter N, Oliver T. Powles T, et al. Among authors: oliver t. Ann Oncol. 2008 Mar;19(3):443-7. doi: 10.1093/annonc/mdm540. Epub 2007 Nov 28. Ann Oncol. 2008. PMID: 18048383 Free article.

4

A phase II study of mitomycin, fluorouracil, folinic acid, and irinotecan (MFI) for the treatment of transitional cell carcinoma of the bladder.

Bhattacharyya M, Powles T, Mutsvangwa K, Wilson P, Oliver T, Shamash J. Bhattacharyya M, et al. Among authors: oliver t. Urol Oncol. 2013 Aug;31(6):878-82. doi: 10.1016/j.urolonc.2011.07.015. Epub 2011 Sep 3. Urol Oncol. 2013. PMID: 21890383 Clinical Trial.

5

A comparison of the platinum analogues in bladder cancer cell lines.

Powles T, Perry J, Shamash J, Liu W, Oliver T, Joel S. Powles T, et al. Among authors: oliver t. Urol Int. 2007;79(1):67-72. doi: 10.1159/000102917. Urol Int. 2007. PMID: 17627172

6

The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer.

Powles T, McFaul S, Stebbing J, Wilson P, Oliver T, Tranter N, Shamash J. Powles T, et al. Among authors: oliver t. Onco Targets Ther. 2008 Sep 1;1:35-9. doi: 10.2147/ott.s3590. Onco Targets Ther. 2008. PMID: 21127750 Free PMC article.

7

A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours.

Shamash J, Powles T, Mutsvangwa K, Wilson P, Ansell W, Walsh E, Berney D, Stebbing J, Oliver T. Shamash J, et al. Among authors: oliver t. Ann Oncol. 2007 May;18(5):925-30. doi: 10.1093/annonc/mdm002. Epub 2007 Mar 12. Ann Oncol. 2007. PMID: 17355956 Free article. Clinical Trial.

8

A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer.

Shamash J, Davies A, Ansell W, Mcfaul S, Wilson P, Oliver T, Powles T. Shamash J, et al. Among authors: oliver t. Br J Cancer. 2008 Jan 15;98(1):22-4. doi: 10.1038/sj.bjc.6604051. Epub 2008 Jan 8. Br J Cancer. 2008. PMID: 18182976 Free PMC article. Clinical Trial.

9

The changing presentation of germ cell tumours of the testis between 1983 and 2002.

Powles TB, Bhardwa J, Shamash J, Mandalia S, Oliver T. Powles TB, et al. Among authors: oliver t. BJU Int. 2005 Jun;95(9):1197-200. doi: 10.1111/j.1464-410X.2005.05504.x. BJU Int. 2005. PMID: 15892800

10

Outcome of patients with HIV-related germ cell tumours: a case-control study.

Powles T, Bower M, Shamash J, Stebbing J, Ong J, Daugaard G, De Ruiter A, Johnson M, Fisher M, Anderson J, Nelson M, Gazzard B, Oliver T. Powles T, et al. Among authors: oliver t. Br J Cancer. 2004 Apr 19;90(8):1526-30. doi: 10.1038/sj.bjc.6601762. Br J Cancer. 2004. PMID: 15083180 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

812 results

Search Page